Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced the publication of data in the May issue of Immunity regarding antibodies with significant potency and breadth against human immunodeficiency virus .
http://ift.tt/1gXFTbP
http://ift.tt/1gXFTbP
No comments:
Post a Comment